FDA Inspection
Bayer AGBayer AG – FDA Inspection, Sep 7, 2023
Record Details
This FDA Inspection record concerns Bayer AG, with an inspection on September 7, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Bayer AG
- Inspection Date
- September 7, 2023
- Product Type
- Drugs
View Company Profile
ID · 745504cb-756f-4fe2-a8a1-01c5a1c51700
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1247034
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Bayer AG
8| Date | Classification | Office | Project area |
|---|---|---|---|
| May 13, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 27, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 22, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 20, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 3, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bayer AG
- FDA Inspection 1209999 - 2022-05-13
- FDA Inspection 1125538 - 2020-07-27
- FDA Inspection 1084360 - 2019-03-22
- FDA Inspection 1004195 - 2017-01-20
- FDA Inspection 975815 - 2016-06-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.